1
|
Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.
|
PLoS Clin Trials
|
2006
|
2.72
|
2
|
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial.
|
PLoS Clin Trials
|
2007
|
2.63
|
3
|
Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study.
|
J Infect Dis
|
2005
|
2.51
|
4
|
Improved malaria case management after integrated team-based training of health care workers in Uganda.
|
Am J Trop Med Hyg
|
2008
|
2.42
|
5
|
Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.
|
J Infect Dis
|
2006
|
1.93
|
6
|
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis.
|
Malar J
|
2009
|
1.80
|
7
|
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.
|
Malar J
|
2011
|
1.73
|
8
|
Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda.
|
Malar J
|
2014
|
1.73
|
9
|
Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
|
Am J Trop Med Hyg
|
2005
|
1.53
|
10
|
Evaluation of a comprehensive refresher training program in malaria microscopy covering four districts of Uganda.
|
Am J Trop Med Hyg
|
2011
|
1.45
|
11
|
Improved clinical and laboratory skills after team-based, malaria case management training of health care professionals in Uganda.
|
Malar J
|
2012
|
1.20
|
12
|
Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at 7 sites in Uganda.
|
J Infect Dis
|
2006
|
1.11
|
13
|
The effect of indoor residual spraying on malaria and anemia in a high-transmission area of northern Uganda.
|
Am J Trop Med Hyg
|
2013
|
1.05
|
14
|
Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda.
|
Malar J
|
2008
|
1.02
|
15
|
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.
|
BMC Med
|
2015
|
0.99
|
16
|
Estimation of malaria haplotype and genotype frequencies: a statistical approach to overcome the challenge associated with multiclonal infections.
|
Malar J
|
2014
|
0.89
|
17
|
Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
|
Malar J
|
2012
|
0.86
|
18
|
Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.
|
PLoS One
|
2013
|
0.85
|
19
|
Long-lasting insecticide-treated bed net ownership and use among children under five years of age following a targeted distribution in central Uganda.
|
Malar J
|
2014
|
0.85
|